Stock Events

Stock Events

Silexion Therapeutics (SLXN) Q2 2026 Earnings

18MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-12.9

-9.56

-6.22

-2.88

Details

Expected EPS

-12.9

Actual EPS

-8.5

Surprise EPS

4.4

Surprise Percent

+34.11%

Description

Silexion Therapeutics (SLXN) has reported earnings of -8.5 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.